Form D · Biotechnology
PSYENCE BIOMEDICAL LTD.
Toronto, A6 · CIK 0001985062
Offering snapshot reported Jan 7, 2025 · SEC filing
- Reported sold
- $2M Offering amount: $2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 27, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 7, 2025 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $150K
- Finders' fees
- $0
- Form D file number
- 021-534475
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co. | 000000375 |
Source: Form D, filed Jan 7, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jody Aufrichtig | Director, Executive |
| Marc Balkin | Director |
| Bull Christopher | Director |
| Warwick Corden Lloyd | Executive |
| Dr. Seth Feuerstein | Director |
| Neil Maresky | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
121 Richmond Street West Penthouse Suite 1300
Toronto, A6, M5H 2K1
Toronto, A6, M5H 2K1